Description
Cabergoline 0.25 mg (CABERFORD 0.25) is a dopamine agonist primarily used to manage conditions related to high prolactin levels in the body (hyperprolactinemia).
Uses / Indications
-
Hyperprolactinemia: Treatment of abnormally high serum prolactin (can cause menstrual irregularities, galactorrhea, infertility in women; decreased libido and sexual dysfunction in men).
-
Menstrual/fertility problems: Restores normal menstruation and ovulation in women with prolactin-related issues.
-
Suppression of lactation: Used post-childbirth, stillbirth, abortion, or miscarriage if stopping or preventing milk production is required for medical reasons.
-
Pituitary prolactinomas: Used for tumors of the pituitary gland that produce prolactin.
-
Adjunct for Parkinson’s disease and acromegaly: Rarely used in these indications due to newer alternatives.
How it Works
-
Stimulates dopamine D2 receptors on cells in the pituitary gland, leading to potent suppression of prolactin secretion.
-
Normalizes serum prolactin, restoring menstrual cycling, fertility, and reducing symptoms related to elevated prolactin.
Dosage & Administration
-
Typical starting dose: 0.25 mg twice weekly; may be gradually increased based on prolactin levels and response.
-
Maximum: Usually not exceeding 1–2 mg per week; dose can be split into two or more days.
-
Take with or after food, as advised by your doctor; follow physician dosage and duration strictly.
Safety & Side Effects
-
Common: nausea, headache, dizziness, stomach pain, constipation, weakness, fatigue.
-
Serious/rare: hallucinations, confusion, nasal stuffiness, low blood pressure, or cardiac valve changes (especially on higher/long-term doses).
-
Contraindicated in severe liver disease, uncontrolled hypertension in pregnancy, or history of heart valve disorders.
-
Not for use in children; caution in elderly or those with mental health disorders.
-
Regular blood prolactin checks and periodic heart valve monitoring may be prescribed during long-term therapy.
Note:
Always use under medical supervision, do not stop abruptly, and inform the doctor of all other ongoing medicines.
Leave a Reply